van Hattum, A. H., Hoogsteen, I. J., Schlüper, H. M. M., Maliepaard, M., Scheffer, G. L., Scheper, R. J., . . . Boven, E. (2002). Induction of breast cancer resistance protein by the camptothecin derivative DX-8951f is associated with minor reduction of antitumour activity. Nature Publishing Group.
Chicago Style citaatvan Hattum, A H., et al. Induction of Breast Cancer Resistance Protein By the Camptothecin Derivative DX-8951f Is Associated With Minor Reduction of Antitumour Activity. Nature Publishing Group, 2002.
MLA citatievan Hattum, A H., et al. Induction of Breast Cancer Resistance Protein By the Camptothecin Derivative DX-8951f Is Associated With Minor Reduction of Antitumour Activity. Nature Publishing Group, 2002.
Let op: Deze citaties zijn niet altijd 100% accuraat.